Private Capital Management (Florida)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.28M Sell
114,887
-2,268
-2% -$60.3K 0.31% 52
2026
Q2
$2.82M Buy
117,155
+19,038
+19% +$498K 0.25% 57
2026
Q1
$2.76M Buy
98,117
+8,208
+9% +$219K 0.27% 54
2025
Q4
$2.24M Sell
89,909
-13,891
-13% -$350K 0.21% 57
2025
Q3
$2.64M Buy
103,800
+17,308
+20% +$427K 0.24% 57
2025
Q2
$2.1M Buy
86,492
+10,008
+13% +$233K 0.2% 58
2025
Q1
$1.94M Buy
76,484
+308
+0.4% +$8.06K 0.21% 52
2024
Q4
$2.02M Buy
76,176
+3,208
+4% +$87K 0.21% 48
2024
Q3
$2.11M Buy
72,968
+3,611
+5% +$105K 0.23% 48
2024
Q2
$1.94M Buy
69,357
+30,006
+76% +$826K 0.23% 48
2024
Q1
$1.09M Buy
39,351
+1,208
+3% +$33.5K 0.12% 57
2023
Q4
$1.1M Sell
38,143
-8,000
-17% -$242K 0.12% 64
2023
Q3
$1.53M Buy
46,143
+39,500
+595% +$1.4M 0.18% 54
2023
Q2
$244K Buy
+6,643
New +$259K 0.03% 124
2023
Q1
– Sell
-8,843
Closed -$453K – 142
2022
Q4
$453K Hold
8,843
– – 0.06% 68
2022
Q3
$387K Buy
+8,843
New +$430K 0.06% 85

Other funds holding PFE

Private Capital Management (Florida)'s PFE Position: Q3 2026 in Review

Private Capital Management (Florida) reduced its Pfizer (PFE) stake by 1.9% in Q3 2026, selling an estimated $60.3K and leaving 114,887 shares worth $3.28M. The position accounts for 0.31% of the portfolio, ranked #52.

Private Capital Management (Florida) first reported a position in PFE in Q3 2022 and has held it in 16 quarters since. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Private Capital Management (Florida) held 114,887 shares of Pfizer worth $3.28M as of Q3 2026.
  • Private Capital Management (Florida) sold 2,268 Pfizer shares in Q3 2026, an estimated $60.3K.
  • Pfizer made up 0.31% of Private Capital Management (Florida)'s portfolio in Q3 2026, its #52 holding.
  • Private Capital Management (Florida) first reported a position in Pfizer in Q3 2022 and has held it in 16 quarters since.
  • 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Private Capital Management (Florida)'s 13F filing for Q3 2026, filed 16 Nov 2026.